Samrat Pharmachem Other Announcement
Samrat Pharmachem Ltd filed its quarterly shareholding pattern as mandated by SEBI regulations. This is a routine compliance disclosure detailing the company's ownership structure.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
7 announcements with these filters
Samrat Pharmachem Ltd filed its quarterly shareholding pattern as mandated by SEBI regulations. This is a routine compliance disclosure detailing the company's ownership structure.
Samrat Pharmachem will hold a board meeting on November 14, 2026, to consider its unaudited quarterly financial results for the period ended September 2026.
Samrat Pharmachem Limited appointed M/s Divyesh J Shah & Associates as Statutory Auditors following the expiry of the previous auditor's tenure at the 34th Annual General Meeting.
Samrat Pharmachem Limited held its 34th Annual General Meeting on September 23, 2026. The meeting successfully transacted the business items outlined in the prior meeting notice.
Samrat Pharmachem will hold its 34th Annual General Meeting on September 23, 2026, via video conferencing. The company also announced book closure dates for shareholders.
Samrat Pharmachem filed its 34th Annual Report for FY 2025-26. The company's 34th AGM is scheduled for September 23, 2026, via video conferencing.
Samrat Pharmachem Ltd reported revenue from operations of ₹79.8 Cr (+5.4% YoY) and net profit of ₹0.9 Cr for Q1 FY27.